News

We were invited to participate in a new clinical trial conducted by the pharmaceutical company Bayer: a new anticoagulant for the treatment of atrial fibrillation.

Screening of patients for the TT-06 clinical trial, sponsored by Alk-Abello, has been properly completed

The selection to participate in a randomized trial to assess the tolerability, safety, and immunogenicity of a new influenza vaccine in children aged 6 months to 17 years has been successfully completed in our Site.

A big event in the world of clinical research specialists: the III International Conference "The life path of medicines: simple and complex tasks", Yaroslavl. Thanks to the organizers for the opportunity to meet with colleagues in person!